Stem, Inc. (STEM) Spending and interest coverage
- R&D / revenue · 12 months: Value 18.24%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 5.41%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 18.24% | Research and development expense / revenue. Period ending 2026-06-30. $27.01M ÷ $148.03M × 100 ≈ 18.24% |
| Stock-based compensation / revenue · 12 months | 5.41% | Share-based compensation / revenue. Period ending 2026-06-30. $8.01M ÷ $148.03M × 100 ≈ 5.41% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 27.01M USD | Research and Development Expense |
| Revenue | 148.03M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 8.01M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -43.08M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $27.01M | $148.03M | $8.01M | $-43.08M | (m) | 18.24% | 5.41% | (m) | (m) |
| 2026-03-31 | $30.54M | $152.75M | $7.95M | $-48.75M | (m) | 19.99% | 5.20% | (m) | (m) |
| 2025-12-31 | $35.30M | $156.27M | $10.22M | $-55.69M | (m) | 22.59% | 6.54% | (m) | (m) |
| 2025-09-30 | $39.02M | $164.95M | $4.68M | $-94.48M | (m) | 23.65% | 2.84% | (m) | (m) |
| 2025-06-30 | $43.19M | $156.00M | $9.00M | $-226.09M | (m) | 27.68% | 5.77% | (m) | (m) |
| 2025-03-31 | $48.47M | $151.63M | $14.41M | $-792.59M | (m) | 31.97% | 9.51% | (m) | (m) |
| 2024-12-31 | $51.28M | $144.58M | $18.47M | $-839.46M | (m) | 35.47% | 12.78% | (m) | (m) |
| 2024-09-30 | $54.99M | $256.18M | $38.51M | $-825.83M | (m) | 21.47% | 15.03% | (m) | (m) |
| 2024-06-30 | $58.33M | $360.63M | $43.17M | $-749.65M | (m) | 16.17% | 11.97% | (m) | (m) |
| 2024-03-31 | $57.20M | $419.58M | $46.28M | $-204.67M | $17.91M | 13.63% | 11.03% | -11.43× | Reported |
| 2023-12-31 | $56.51M | $461.51M | $45.11M | $-179.31M | $14.98M | 12.24% | 9.77% | -11.97× | Reported |
| 2023-09-30 | $51.89M | $449.54M | $36.57M | $-179.54M | $12.12M | 11.54% | 8.14% | -14.81× | Reported |
| 2023-06-30 | $48.00M | $415.30M | $33.05M | $-143.87M | $10.24M | 11.56% | 7.96% | -14.05× | Reported |
| 2023-03-31 | $42.80M | $389.30M | $29.60M | $-138.82M | $9.03M | 11.00% | 7.60% | -15.38× | Reported |
| 2022-12-31 | $38.30M | $362.98M | $28.66M | $-131.12M | $10.47M | 10.55% | 7.90% | -12.53× | Reported |
| 2022-09-30 | $35.65M | $260.32M | $25.97M | $-127.56M | $12.99M | 13.70% | 9.98% | -9.82× | Reported |
| 2022-06-30 | $31.39M | $200.65M | $24.49M | $-114.09M | $13.14M | 15.65% | 12.21% | -8.68× | Reported |
| 2022-03-31 | $27.26M | $153.04M | $19.05M | $-108.14M | $14.38M | 17.81% | 12.45% | -7.52× | Reported |
| 2021-12-31 | $22.72M | $127.37M | $13.55M | $-83.07M | $17.39M | 17.84% | 10.64% | -4.78× | Reported |
| 2021-09-30 | (m) | (m) | (m) | $-19.73M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | $-13.07M | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | $-1.19M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | $-3.50M | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $14.70M | $17.55M | $1.53M | $-47.85M | $12.55M | 83.77% | 8.72% | -3.81× | Reported |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE REALITIES, INC. (CREX) | United States | $0.036B | -2.64 |
| Brand Engagement Network Inc. (BNAI) | United States | $0.048B | |
| Odysight.ai Inc. (ODYS) | $0.054B | -3.84 | |
| Fusemachines Inc. (FUSE) | United States | $0.017B | |
| Healthcare Triangle, Inc. (HCTI) | United States | $0.011B | |
| Super League Enterprise, Inc. (SLE) | United States | $0.009B | -0.20 |
| Algorhythm Holdings, Inc. (RIME) | United States | $0.003B | -0.61 |
| CSP INC /MA/ (CSPI) | United States | $0.077B | -117.69 |
| CID Holdco, Inc. (DAIC) | United States | $0.103B | |
| WIDEPOINT CORP (WYY) | United States | $0.109B | -137.61 |